Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE

Mid Cap | Pharmaceuticals & Drugs

927.15

-19.95 (-2.11%)

< Home < Back

Zydus Lifesciences Ltd. News

>>

Zydus Lifesciences submits press release

>>

Zydus Lifesciences gets USFDA’s final approval for Jaythari (Deflazacort) Tablets

>>

Zydus Lifesciences informs about newspaper publication

>>

Zydus Lifesciences moves up on getting USFDA’s final approval for Apalutamide Tablets

>>

Zydus Lifesciences gets USFDA’s final approval for Apalutamide Tablets

>>

Zydus Lifesciences gains on getting USFDA’s final approval for Eluxadoline tablets

>>

Zydus Lifesciences gets USFDA’s final approval for Eluxadoline tablets

>>

USFDA concludes inspection at Zydus group’s API Unit 1 in Gujarat

>>

Zydus Lifesciences informs about press release

>>

Zydus Lifesciences moves up as its venture capital arm invests in Illexcor Therapeutics

<< < 15 16 17 ...168 > >>